Summary - A new Market study, titled “Blood Transfusion Diagnostics Market Research Report - Forecast to 2023” has been featured on WiseGuyReports.
Report Description
This report analyzes the global blood transfusion diagnostics market by product (red blood cells, platelets, plasma, albumin, immunoglobulin preparations, others) by technology (western blot, ELISA, nucleic acid amplification, fluorescence assay, rapid test, others) by end user (hospitals, clinics, blood banks, laboratories); it also studies the top manufacturers in the market.
The global blood transfusion diagnostics market was valued at USD 1.50 billion in 2016 and is projected to reach USD 2.45 billion in 2023, at a CAGR of 8.2% during the forecast period 2017-2023.
The major players in global blood transfusion diagnostics market include:
- Grifols (Spain)
- Thermo Fisher Scientific, Inc. (U.S.)
- Roche Diagnostics (Switzerland)
- bioMérieux (France)
- Bio-Rad Laboratories, Inc. (U.S.)
- Immucor (U.S)
- Siemens Healthineers (Germany)
- Ortho Clinical Diagnostics, Inc. (U.S.)
- Becton, Dickinson and Company (U.S.)
- Novartis AG (Switzerland)
- Beckman Coulter, Inc. (U.S.)
- Ortho Clinical Diagnostics (U.S)
- Beckman Coulter (U.S)
- Diagast (France)
- Abbott Diagnostics (U.S)
- BAG healthcare (Germany)
- DiaSorin (Italy)
- Fujirebio (Belgium)
- Grifols (Spain)
- Quidel (U.S)
- Hologic/Gen-Probe (U.S)
- Biokit (Spain)
The market revenue and share have been analyzed with respect to the following regions and countries:
Americas
North America
U.S.
Canada
South America
Europe
Western Europe
U.K.
France
Germany
Italy
Spain
Rest of Western Europe
Eastern Europe
Asia-Pacific
China
Japan
India
Australia
Republic of Korea
Rest of Asia-Pacific
Middle East and Africa
United Arab Emirates
Saudi Arabia
Oman
Qatar
Kuwait
Rest of Middle East and Africa
On the basis of product, the global blood transfusion diagnostics market has been categorized into the following segments:
- Red Blood Cells
- Platelets
- Plasma
- Albumin
- Immunoglobulin Preparations
- Others
On the basis of technology, the global blood transfusion diagnostics market has been categorized into the following segments:
- Western Blot
- ELISA
- Nucleic Acid Amplification
- Fluorescence assay
- Rapid Test
- Others
On the basis of end user, the global blood transfusion diagnostics market has been categorized into the following segments:
- Hospitals
- Clinics
- Blood banks
- Laboratories
Research Methodology
Market Research Future analysis is conducted by industry experts who offer insight into industry structure, market segmentation, technology assessment, competitive landscape (CL), and market penetration, as well as on emerging trends. Besides primary interviews (~80%) and secondary research (~20%), their analysis is based on years of professional expertise in their respective industries. Our analysts also predict where the market will be headed in the next five to 10 years, by analyzing historical trends and current market positions. Furthermore, the varying trends of segments and categories in different regions are estimated based on primary and secondary research.
Both the top-down and bottom-up approaches were used to estimate and validate the size of the market and to estimate the size of various other dependent sub-markets. The key players in the market were identified through secondary research, and their market contributions in the respective regions were determined through primary and secondary research. This entire process included the study of the annual and financial reports of the top market players and extensive interviews for key insights with industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All the possible parameters that affect the market covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to arrive at the final quantitative and qualitative data. This data has been consolidated, and detailed inputs and analysis by Market Research Future added before being presented in this report.
FOR MORE DETAILS: https://www.wiseguyreports.com/reports/3462538-blood-transfusion-diagnostics-market-research-report-forecast-to-2023
About Us:
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, Markett research reports, analysis & forecast data for industries and governments around the globe.
Contact Us:
NORAH TRENT
Ph: +162-825-80070 (US)
Ph: +44 203 500 2763 (UK)
A recent report published by TheBusinessResearchCompany on Blood Transfusion Diagnostics Market provides in-depth analysis of segments and sub-segments in the global as well as regional.The Blood Transfusion Diagnostics Global Market Report 2020 which provides strategists, marketers and senior management with the critical information they need to assess the global blood transfusion diagnostics market.
the report covers the blood transfusion diagnostics market’s segments- instruments and kits, reagents, hospitals, diagnostic laboratories, blood banks, plasma fractionation companies, western blot, ELISA, nucleic acid amplification, fluorescence assay, rapid test, blood grouping, and disease screening.Blood Transfusion Diagnostics Global Market Report 2020 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country.
It also compares the market’s historic and forecast growth.It covers all the regions, key developed countries and major emerging markets.
It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
The major regions included in the report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.The growing demand for advanced diagnostic measures and growing prevalence of infectious diseases associated with pathogens such as bacteria & viruses increase the preference for nucleic acid amplification testing (NAAT/NAT) to increase blood safety, improve efficiency, and reduce turnaround time of the results.
Global Blood Transfusion Diagnostics Market Information, by product (Red Blood Cells, Platelets, Plasma, Albumin, Immunoglobulin Preparations, others) by Technology (Western Blot, ELISA, Nucleic Acid Amplification, Fluorescence assay, Rapid Test, others) by end user (Hospitals, Clinics, Blood banks, Laboratories) - Forecast till 2027Ortho Clinical Diagnostics (U.S), Immucor (U.S), Beckman Coulter (U.S), Grifols (Spain), Thermo Fisher Scientific, Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), bioMérieux (France), Bio-Rad Laboratories, Inc. (U.S.), Siemens (Germany), Becton, Dickinson and Company (U.S.), Novartis AG (Switzerland), Beckman Coulter, Inc. (U.S.), Diagast (France), Abbott Diagnostics (U.S), BAG healthcare (Germany), DiaSorin (Italy), Fujirebio (Belgium), Grifols (Spain), Quidel (U.S), Hologic/Gen-Probe (U.S), Biokit (Spain).are some of the prominent players at the forefront of competition in the global Blood Transfusion Diagnostics market and top seven players are profiled in MRFR Analysis.
However, the growth of the market is restrained by various factors such as risk involved in transmission of infectious disease from one person to another without carrying out screening procedure.Global Blood Transfusion Diagnostics Market - Competitive AnalysisThere is a significant increase in the number of the company offering blood transfusion diagnostics.
Some major companies are trying to focus on new and advanced tests & products to gain the market.
Whereas, some are has used the technique of acquisition and collaboration to gain the market.Hoffmann-La Roche AG:August, 2015: F. Hoffmann-La Roche AG acquired GeneWEAVE to strengthen offerings in microbiology diagnostics.
This merger will further strengthen the global presence of the company.August, 2016: Abbott announced the introduction of its new “Alinity”, a family of next generation systems across immunoassay, clinical chemistry, point of care, haematology, blood and plasma screening and molecular diagnostics.April, 2016: The company received FDA approval for its companion diagnostics “Vysis CLL FISH probe kit” in Leukemia.
The kit is used to detect the 17p deletion in chronic lymphocytic leukemia patients, the target population of a new drug from AbbVie.Bio-Rad Laboratories, Inc.:July 2017: Bio-Rad Laboratories, Inc., a global provider of life science research and clinical diagnostic products launched Amplichek I quality control for the testing of infectious diseases.Request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/1126Global Blood Transfusion Diagnostics Market - Regional AnalysisGlobally, America’s account for the largest market share in blood transfusion diagnostics market consists of two regions namely North America and South America.
